Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P203
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eissler, Nina
Sveinbjörnsson, Baldur
Kock, Anna
Johnsen, John Inge
Kogner, Per
Article History
First Online: 6 November 2014